Athira Pharma raises $85 million in Series B round
The Seattle-based company is one of several that have raised venture capital and equity investment funding this week.
Orchard Therapeutics closes $150 million Series C round
The oversubscribed round comes just four months after acquisition of GSK's gene therapy portfolio.
The New Blueprint: How Clever Care Health Plan is Scaling Its Member Experience [Video]
MedCity News was at the Vive conference and spoke with executives who shared their insights for the healthcare industry.
Therachon raises $60 million in mezzanine financing for rare disease drugs
The Basel, Switzerland-based biotech company plans to trial the drug in achondroplasia patients next year.